Security key
74006W108
- Security type / class
- Equity / COM
- Total 13F shares
- 114,399,484
- Total 13F value
- $195,621,596
- Share change
- -4,849,523
- SEC-reported price per share
- $1.71
- Number of holders
- 74
- Value change
- -$6,795,329
- Number of buys
- 32
- Number of sells
- 34
Report period
Q3 2023
Institutions
74
Top holders
10
PRAX full security history
Ownership snapshot
Full 13F holder table
Praxis Precision Medicines, Inc. SEC filings
Praxis Precision Medicines, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of PRAX - PRAXIS PRECISION MEDICINES I - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Clarus Lifesciences III, ...
Disclosed value leader
Clarus Lifesciences III, ...
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5
13F
Highest disclosed value: $123,282,606
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Clarus Lifesciences III, L.P. has the largest disclosed position value at $123.28M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Clarus Lifesciences III, L.P.'s linked filing trail.
Disclosed position value
Top 5
Clarus Lifesciences III, L.P.
$123.28M
Point72 Asset Management, L.P.
$12.13M
Verition Fund Management LLC
$12.06M
Cormorant Asset Management, LP
$10.92M
PFM Health Sciences, LP
$10.23M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Clarus Lifesciences III, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$123,282,606
4,894,109 shares
|
— | 12 May 2021 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$12,132,500
10,550,000 shares
|
— | 30 Jun 2023 |
| Verition Fund Management LLC |
13F
Company
|
—
denominator unverified
|
$12,061,002
10,487,828 shares
|
— | 30 Jun 2023 |
| Cormorant Asset Management, LP |
13F
Company
|
—
denominator unverified
|
$10,925,000
9,500,000 shares
|
— | 30 Jun 2023 |
| PFM Health Sciences, LP |
13F
Company
|
—
denominator unverified
|
$10,225,526
8,891,762 shares
|
— | 30 Jun 2023 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
—
denominator unverified
|
$10,078,984
8,764,334 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
114,399,484
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
77
Q3 2023 holders
74
Holder diff
-3
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|